Wave Life Sciences Ltd.
WVE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $7,608 | $8,699 | $9,175 | $83,748 |
| % Growth | -12.5% | -5.2% | -89% | – |
| Cost of Goods Sold | $0 | $2,196 | $2,164 | $0 |
| Gross Profit | $7,608 | $6,503 | $7,011 | $83,748 |
| % Margin | 100% | 74.8% | 76.4% | 100% |
| R&D Expenses | $45,874 | $43,469 | $40,622 | $44,645 |
| G&A Expenses | $18,087 | $17,989 | $18,357 | $16,136 |
| SG&A Expenses | $18,087 | $17,989 | $18,357 | $16,136 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2,196 | -$2,164 | $0 |
| Operating Expenses | $63,961 | $59,262 | $56,815 | $60,781 |
| Operating Income | -$56,353 | -$52,759 | -$49,804 | $22,967 |
| % Margin | -740.7% | -606.5% | -542.8% | 27.4% |
| Other Income/Exp. Net | $2,501 | $2,290 | $2,926 | $6,286 |
| Pre-Tax Income | -$53,852 | -$50,469 | -$46,878 | $29,253 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$53,852 | -$50,469 | -$46,878 | $29,253 |
| % Margin | -707.8% | -580.2% | -510.9% | 34.9% |
| EPS | -0.32 | -0.31 | -0.29 | 0.18 |
| % Growth | -3.2% | -6.9% | -261.1% | – |
| EPS Diluted | -0.32 | -0.31 | -0.29 | 0.17 |
| Weighted Avg Shares Out | 167,739 | 163,988 | 162,527 | 161,488 |
| Weighted Avg Shares Out Dil | 167,739 | 163,988 | 162,527 | 172,290 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,177 | $2,372 | $2,875 | $3,738 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2,230 | $2,196 | $2,164 | $2,156 |
| EBITDA | -$51,622 | -$50,563 | -$47,640 | $25,123 |
| % Margin | -678.5% | -581.3% | -519.2% | 30% |